221 related articles for article (PubMed ID: 32560274)
1. RIG-I Plays a Dominant Role in the Induction of Transcriptional Changes in Zika Virus-Infected Cells, which Protect from Virus-Induced Cell Death.
Schilling M; Bridgeman A; Gray N; Hertzog J; Hublitz P; Kohl A; Rehwinkel J
Cells; 2020 Jun; 9(6):. PubMed ID: 32560274
[TBL] [Abstract][Full Text] [Related]
2. NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I Signaling.
Li A; Wang W; Wang Y; Chen K; Xiao F; Hu D; Hui L; Liu W; Feng Y; Li G; Tan Q; Liu Y; Wu K; Wu J
Front Immunol; 2020; 11():51. PubMed ID: 32117232
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
[TBL] [Abstract][Full Text] [Related]
4. Infection with a Brazilian isolate of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling.
Hertzog J; Dias Junior AG; Rigby RE; Donald CL; Mayer A; Sezgin E; Song C; Jin B; Hublitz P; Eggeling C; Kohl A; Rehwinkel J
Eur J Immunol; 2018 Jul; 48(7):1120-1136. PubMed ID: 29572905
[TBL] [Abstract][Full Text] [Related]
5. Zika Virus-Encoded NS2A and NS4A Strongly Downregulate NF-κB Promoter Activity.
Lee JY; Nguyen TTN; Myoung J
J Microbiol Biotechnol; 2020 Nov; 30(11):1651-1658. PubMed ID: 33203823
[TBL] [Abstract][Full Text] [Related]
6. Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon.
Lundberg R; Melén K; Westenius V; Jiang M; Österlund P; Khan H; Vapalahti O; Julkunen I; Kakkola L
Viruses; 2019 Nov; 11(11):. PubMed ID: 31690057
[TBL] [Abstract][Full Text] [Related]
7. Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce IFN-β Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway.
Ngueyen TTN; Kim SJ; Lee JY; Myoung J
J Microbiol Biotechnol; 2019 Oct; 29(10):1665-1674. PubMed ID: 31581385
[TBL] [Abstract][Full Text] [Related]
8. Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity.
Riedl W; Acharya D; Lee JH; Liu G; Serman T; Chiang C; Chan YK; Diamond MS; Gack MU
Cell Host Microbe; 2019 Oct; 26(4):493-503.e6. PubMed ID: 31600501
[TBL] [Abstract][Full Text] [Related]
9. Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes.
Kim JA; Seong RK; Son SW; Shin OS
J Invest Dermatol; 2019 Feb; 139(2):391-399. PubMed ID: 30218650
[TBL] [Abstract][Full Text] [Related]
10. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
[TBL] [Abstract][Full Text] [Related]
11. Viral Protein Accumulation of Zika Virus Variants Links with Regulation of Innate Immunity for Differential Control of Viral Replication, Spread, and Response to Interferon.
Lu AY; Gustin A; Newhouse D; Gale M
J Virol; 2023 May; 97(5):e0198222. PubMed ID: 37162358
[TBL] [Abstract][Full Text] [Related]
12. Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.
Grant A; Ponia SS; Tripathi S; Balasubramaniam V; Miorin L; Sourisseau M; Schwarz MC; Sánchez-Seco MP; Evans MJ; Best SM; García-Sastre A
Cell Host Microbe; 2016 Jun; 19(6):882-90. PubMed ID: 27212660
[TBL] [Abstract][Full Text] [Related]
13. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling.
Bos S; Poirier-Beaudouin B; Seffer V; Manich M; Mardi C; Desprès P; Gadea G; Gougeon ML
Front Immunol; 2020; 11():582061. PubMed ID: 33193389
[TBL] [Abstract][Full Text] [Related]
14. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
[TBL] [Abstract][Full Text] [Related]
15. Innate immune response in patients with acute Zika virus infection.
da Silva MHM; Moises RNC; Alves BEB; Pereira HWB; de Paiva AAP; Morais IC; Nascimento YM; Monteiro JD; de Souto JT; Nascimento MSL; de Araújo JMG; da Guedes PMM; Fernandes JV
Med Microbiol Immunol; 2019 Dec; 208(6):703-714. PubMed ID: 30879197
[TBL] [Abstract][Full Text] [Related]
16. Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.
Chaudhary V; Yuen KS; Chan JF; Chan CP; Wang PH; Cai JP; Zhang S; Liang M; Kok KH; Chan CP; Yuen KY; Jin DY
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468880
[TBL] [Abstract][Full Text] [Related]
17. INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation.
Fanunza E; Grandi N; Quartu M; Carletti F; Ermellino L; Milia J; Corona A; Capobianchi MR; Ippolito G; Tramontano E
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960717
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role of the ZIKV NS5 Nuclear Spherical-Shell Structures in Cell Type-Specific Host Immune Modulation during ZIKV Infection.
Tan MJA; Chan KWK; Ng IHW; Kong SYZ; Gwee CP; Watanabe S; Vasudevan SG
Cells; 2019 Nov; 8(12):. PubMed ID: 31779251
[TBL] [Abstract][Full Text] [Related]
19. A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
Ye X; Liu X; Shu T; Deng W; Liao M; Zheng Y; Zheng X; Zhang X; Li T; Fan W; Qu L; Chen L; Li F; Feng L
J Virol; 2021 Jun; 95(14):e0038321. PubMed ID: 33910950
[TBL] [Abstract][Full Text] [Related]
20. Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity.
Hu H; Feng Y; He ML
Int J Biol Sci; 2023; 19(10):3015-3028. PubMed ID: 37416780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
